Hansoh Pharmaceutical Group Company Ltd
OTC:HNSPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hansoh Pharmaceutical Group Company Ltd
OTC:HNSPF
|
CN |
|
C
|
Crest Ventures Ltd
BSE:511413
|
IN |
|
WuXi Biologics (Cayman) Inc
F:1FW1
|
CN |
|
H
|
Henry Schein Inc
XETRA:HS2
|
US |
|
A
|
Air China Ltd
HKEX:753
|
CN |
|
Coty Inc
NYSE:COTY
|
US |
|
A
|
Arcelormittal South Africa Ltd
JSE:ACL
|
ZA |
|
S
|
Schoeller Bleckmann Oilfield Equipment AG
XHAM:SLL
|
AT |
|
B
|
Bank Polska Kasa Opieki SA
SWB:BP1
|
PL |
|
M
|
MTN Group Ltd
JSE:MTN
|
ZA |
|
Koninklijke BAM Groep NV
AEX:BAMNB
|
NL |
|
V
|
VF Corp
LSE:0R30
|
US |
|
H
|
Hess Corp
F:AHC
|
US |
|
BigBear.ai Holdings Inc
F:28K1
|
US |
|
T
|
TDK Corp
SWB:TDK
|
JP |
|
Paragon Id SA
PAR:PID
|
FR |
|
ReGen III Corp
F:PN4
|
CA |
|
T
|
Transition Metals Corp
OTC:TNTMF
|
CA |
|
J
|
JAFCO Group Co Ltd
DUS:JAF
|
JP |
|
Itochu Corp
TSE:8001
|
JP |
|
H
|
Hartford Financial Services Group Inc
SWB:HFF
|
US |
|
I
|
IHI Corp
SWB:IWJ
|
JP |
|
S
|
Sanofi SA
XHAM:SNW
|
FR |
|
B
|
Bombardier Inc
TSX:BBD.A
|
CA |
Wall St Price Targets
HNSPF Price Targets Summary
Hansoh Pharmaceutical Group Company Ltd
According to Wall Street analysts, the average 1-year price target for HNSPF is 6.956 USD with a low forecast of 5.705 USD and a high forecast of 8.116 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HNSPF's stock price target?
Price Target
6.956
USD
According to Wall Street analysts, the average 1-year price target for HNSPF is 6.956 USD with a low forecast of 5.705 USD and a high forecast of 8.116 USD.
What is the Revenue forecast for Hansoh Pharmaceutical Group Company Ltd?
Projected CAGR
15%
Over the last 8 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 8 years is 15%.
What is the Operating Income forecast for Hansoh Pharmaceutical Group Company Ltd?
Projected CAGR
14%
Over the last 8 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 8 years is 14%.
What is the Net Income forecast for Hansoh Pharmaceutical Group Company Ltd?
Projected CAGR
20%
Over the last 8 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 8 years is 20%.
